Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction
- 31 January 1997
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 32 (1) , 69-72
- https://doi.org/10.1016/s0022-3468(97)90097-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNAEuropean Journal Of Cancer, 1995
- Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNACancer, 1995
- Use of polymerase chain reaction for improved diagnosis of tuberculosis in childrenThe Journal of Pediatrics, 1995
- Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reactionBritish Journal of Cancer, 1995
- Childhood cancerCancer, 1995
- Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNAInternational Journal of Cancer, 1994
- Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reactionEuropean Journal of Cancer and Clinical Oncology, 1991
- Structure of the Human Tyrosine Hydroxylase Gene: Alternative Splicing from a Single Gene Accounts for Generation of Four mRNA Types1The Journal of Biochemistry, 1988
- Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAsBiochemistry, 1987
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971